Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Attivazione Farmacologica Di HIF-1α Come Nuovo Approccio Terapeutico Per Contrastare La Perdita Di Fibre Glicolitiche in Pazienti Sarcopenici.
Authors not listed
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · 2023
Abstract
Age-related sarcopenia is associated with reduced mobility, functional decline and disability, falls, and mortality in the elderly. Loss of skeletal muscle is the focus of the disease and is the result of progressive atrophy and loss of glycolytic-type muscle fibers. Muscle mass declines at a rate of 3-5% per decade after thirty years, and the decrease accelerates further after sixty years (Patel et al., 2013). As life expectancy increases worldwide, it is clear that sarcopenia is considered a major contributor to healthcare costs and that even a small reduction in the prevalence of sarcopenia could result in substantial savings in healthcare resources (Goates et al., 2019). In this context, the present proposal aims to develop a new therapeutic approach based on the activation of HIF-1alpha, which has been shown to promote skeletal muscle hypertrophy, to prevent and counteract sarcopenia, thereby reducing disability in the elderly and the impact on the national health care system.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2023). Attivazione Farmacologica Di HIF-1α Come Nuovo Approccio Terapeutico Per Contrastare La Perdita Di Fibre Glicolitiche in Pazienti Sarcopenici. <em>I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio</em>. https://clinicaltrials.gov/study/NCT06736249
Vancouver
Anonymous. Attivazione Farmacologica Di HIF-1α Come Nuovo Approccio Terapeutico Per Contrastare La Perdita Di Fibre Glicolitiche in Pazienti Sarcopenici. I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. 2023.
BibTeX
@misc{anon2023Attiva,
title = {Attivazione Farmacologica Di HIF-1α Come Nuovo Approccio Terapeutico Per Contrastare La Perdita Di Fibre Glicolitiche in Pazienti Sarcopenici.},
author = {Anonymous},
journal = {I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Northeast Normal University 2023
Open access · US-GOV
An Alternative Remote Rehabilitation Strategy for the Improvement of Sarcopenia in the Elderly: Tai Chi as an Exercise Form
Archives of Gerontology and Geriatrics 2011
Citation only
The relationship of pre-sarcopenia (low muscle mass) and sarcopenia (loss of muscle strength) with functional decline in individuals with intellectual disability (ID)
GeroScience 2025
Open access · OA
HDAC11 deficiency regulates age-related muscle decline and sarcopenia
Journal of the American Medical Directors Association 2014
Citation only
An Anthropometric Prediction Equation for Appendicular Skeletal Muscle Mass in Combination With a Measure of Muscle Function to Screen for Sarcopenia in Primary and Aged Care
Neuromuscular Disorders 2025
Citation only
123PHDAC11 deficiency regulates age-related muscle decline and sarcopenia
Cells 2022
Open access · CC-BY